Sunshine Biopharma SBFM Income Statement (2010-2026)

NASDAQ SBFM
$1.13 -0.02 (-1.74%)
As of: Sep 9, 2026 · 1:19 PM EDT
Reported Financials

Sunshine Biopharma Quarterly Income Statement

Periods 63 quarters
Latest Jun 2026

Sunshine Biopharma reported revenue of $9.26M and net income of -$1.88M for the quarter ended Jun 2026, down 1.6% year over year. This income statement covers 63 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
0.05M0.09M0.12M0.15M0.13M3.94M4.89M5.56M5.96M7.68M7.54M9.30M8.44M9.59M8.90M9.41M9.42M8.58M8.09M9.26M
Cost of RevenueCost of Rev
0.02M0.06M0.10M0.09M0.22M2.25M3.07M3.61M3.97M5.11M5.19M6.95M5.57M6.50M6.17M5.99M6.34M5.55M5.91M6.84M
Gross Profit
0.03M0.02M0.06M0.08M0.07M1.49M1.83M1.95M1.99M2.57M2.35M2.36M2.87M3.09M2.73M3.42M3.07M3.03M2.18M2.43M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.00M0.00M0.00M0.00M789.000.01M0.03M0.04M0.00M0.04M0.05M0.06M-0.01M0.06M0.07M0.10M-0.06M
Research & DevelopmentR&D
0.22M0.09M0.36M0.05M0.36M0.04M0.43M0.37M0.24M0.82M0.22M0.44M0.13M0.15M0.22M0.20M0.12M0.07M0.03M0.01M
Selling, General & AdministrativeSG&A
0.53M0.30M1.29M0.77M1.79M24.85M3.66M2.97M2.77M3.76M3.70M3.62M3.97M5.13M4.03M5.48M4.16M4.82M3.58M4.04M
Restructuring CostsRestructuring
0.54M0.72M0.91M0.71M0.53M0.91M0.93M0.81M0.61M1.52M0.87M0.76M
Other Operating ExpensesOther Opex
-0.01M-7.00
Operating ExpensesOpex
0.75M0.40M1.65M0.82M2.15M24.91M4.09M3.37M3.59M5.30M4.88M4.82M4.69M6.17M5.23M6.55M4.99M6.35M4.48M4.81M
Operating IncomeOp. Inc
-0.50M-0.28M-1.22M-0.70M-1.72M-23.36M-1.83M-1.01M-0.78M-1.19M-1.35M-1.27M-1.11M-2.04M-1.30M-2.05M-1.09M-1.79M-1.40M-1.61M
EBIT
-0.50M-0.28M-1.22M-0.70M-1.72M-23.36M-1.83M-1.01M-0.78M-1.19M-1.35M-1.27M-1.11M-2.04M-1.30M-2.05M-1.09M-1.79M-1.40M-1.61M
Non-operating items
Non Operating Interest Expenses
0.05M0.04M0.01M2.000.03M0.04M0.00M0.04M0.03M0.05M245.000.01M
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc
0.07M0.05M
Other Non Operating IncomeOther Non Op Inc.
0.01M-0.06M-9.000.01M25.0015.00-261.0040.00-39.00-0.01M0.29M0.02M-0.24M451.000.00M253.000.05M-18.00-6.00
Non Operating IncomeNon Op. Inc.
-3.54M0.95M-0.01M0.16M0.26M0.08M0.17M0.20M0.17M0.16M0.09M0.43M0.12M-0.25M0.08M0.07M0.07M0.06M0.15M0.05M
Net income details
EBT
-4.04M0.67M-1.24M-0.54M-1.46M-23.28M-1.66M-0.81M-0.61M-1.03M-1.26M-0.84M-0.98M-2.29M-1.22M-1.98M-1.02M-1.73M-1.24M-1.56M
Tax ProvisionsTaxes
0.23M0.05M0.09M0.05M0.18M0.08M-0.34M0.22M-0.51M-0.04M-0.21M-0.14M0.43M
Profit After TaxPAT
-4.05M0.83M-1.24M-0.55M-1.50M-23.46M-1.70M-0.90M-1.11M-1.25M-1.83M-1.33M-1.20M-3.16M-1.18M-1.77M-1.49M-2.14M-1.52M-1.88M
Income from Continuing OperationsIncome (Continuing)
-4.04M0.67M-1.24M-0.54M-1.46M-23.51M-1.70M-0.90M-0.66M-1.21M-1.34M-0.49M-1.20M-1.77M-1.18M-1.77M-0.88M-2.16M-1.24M-1.56M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-4.04M0.67M-1.24M-0.54M-1.46M-23.51M-1.70M-0.90M-0.66M-1.21M-1.34M-0.49M-1.20M-1.77M-1.18M-1.77M-0.88M-2.16M-1.24M-1.56M
Income towards Parent CompanyParent Net Inc
-4.04M0.67M-1.24M-0.54M-1.46M-23.51M-1.70M-0.90M-0.66M-1.21M-1.34M-0.49M-1.20M-1.77M-1.18M-1.77M-0.88M-2.16M-1.24M-1.56M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-4.04M0.67M-1.24M-0.54M-1.46M-23.51M-1.70M-0.90M-0.65M-1.21M-1.28M-1.78M-1.20M-2.16M-1.18M-2.95M-0.88M-2.14M-1.24M-1.56M
Additional items
EPS (Basic)
-1.5951.08-46.89-6.80-15.43-309.76-0.00M-7.12-5.07-9.96-400.31-357.55-9.45-30.75-4.36-6.56-1.94-5.15-2.54-1.15
EPS (Diluted)
51.08-46.89-6.80-15.43-309.76-15.45-7.12-5.07-9.96-400.31-357.55-9.45-30.75-4.36-8.19-2.25-5.45-3.17-3.98
Shares Outstanding
2.54M0.01M0.03M0.08M0.09M0.08M0.00M0.13M0.13M0.12M0.00M0.00M0.13M0.07M0.27M0.45M0.46M0.42M0.49M1.37M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.01M0.03M0.08M0.09M0.08M0.11M0.13M0.13M0.12M0.00M0.00M0.13M0.07M0.27M0.36M0.39M0.39M0.39M0.39M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.55M0.01M0.03M0.09M0.09M0.08M0.00M0.13M0.13M0.14M0.00M0.00M0.13M0.07M0.27M0.46M0.49M0.49M0.49M1.37M
EBITDA
-0.49M-0.28M-1.22M-0.69M-1.72M-23.35M-1.83M-0.98M-0.74M-1.18M-1.31M-1.22M-1.04M-2.05M-1.23M-1.98M-0.99M-1.85M-1.40M-1.61M
Interest ExpensesInt Expense
0.05M0.04M0.01M2.000.03M0.04M0.00M0.04M0.03M0.05M245.000.01M
Tax Rate
-1.00%-2.79%-10.77%-8.61%-17.69%-6.02%41.01%-21.90%22.43%3.29%10.56%13.46%-24.89%